A discussion on evidence-based treatment approaches for bipolar mania, focusing on medication selection. Key recommendations include choosing agents that prevent post-manic depression, with quetiapine preferred for mixed mania and lithium for classic mania. The discussion emphasizes consideration of long-term outcomes, maintenance efficacy, and safety when selecting treatments.
- Provider:Medical Academy, LLC
- Activity Link: https://psychopharmacologyinstitute.com/publication/an-update-on-bipolar-mania-algorithm-2868?utm_source=PARS+ACCME&utm_medium=PARS+ACCME&utm_campaign=PARS+ACCME
- Start Date: 2024-12-01 06:00:00
- End Date: 2024-12-01 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Performance
- Provider Ship: Jointly Provided
- Registration: Limited
Subscribe
Login
0 Comments
Oldest